Literature DB >> 8634298

Mechanism of ubiquitin conjugating enzyme E2-230K: catalysis involving a thiol relay?

E S Berleth1, C M Pickart.   

Abstract

Covalent conjugation of ubiquitin to intracellular proteins is a signal for degradation by the 26S protease. Conjugation is usually accomplished by the sequential action of activating (E1), conjugating (E2), and ligase (E3) enzymes. Each of these enzymes forms a covalent thiol ester with ubiquitin as part of its catalytic cycle. In most cases, the apparent role of the ubiquitin conjugating enzyme (E2) is to transfer ubiquitin from the E1 active site to the E3 active site. Ubiquitin is then delivered from E3 to the substrate lysine residue. An unusually large, reticulocyte-specific enzyme, known as E2-230K, is unique among the large family of E2 enzymes is being susceptible to inhibition by inorganic arsenite [Klemperer et al. (1989) Biochemistry 28, 6035-6041]. We show that phenylarsenoxides potently inhibit E2-230K, apparently by binding to vicinal Cys residues of the enzyme: bound aminophenylarsenoxide partially protects the enzyme against inactivation by N-ethylmalemide (NEM), and prior enzyme inactivation with NEM blocks enzyme binding to immobilized phenylarsenoxide. Studies on the mechanistic basis of inhibition showed that a concentration of (aminophenyl)arsenoxide that produced complete inhibition of steady-state turnover had no effect on the turnover of the preformed E2-ubiquitin adduct. However, when the enzyme was preincubated with this concentration of inhibitor prior to initiation of adduct formation, the level of E2-associated ubiquitin was reduced by 60%. These results are consistent with a model in which two Cys residues of the enzyme sequentially form thiol esters with ubiquitin and the second of these Cys residues is bound to arsenic in the enzyme-inhibitor complex. In this model, E2-230K functions as an E2-E3 hybrid.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634298     DOI: 10.1021/bi952105y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

1.  Down-regulation of types I, II and III inositol 1,4,5-trisphosphate receptors is mediated by the ubiquitin/proteasome pathway.

Authors:  J Oberdorf; J M Webster; C C Zhu; S G Luo; R J Wojcikiewicz
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

2.  UBE2O remodels the proteome during terminal erythroid differentiation.

Authors:  Anthony T Nguyen; Miguel A Prado; Paul J Schmidt; Anoop K Sendamarai; Joshua T Wilson-Grady; Mingwei Min; Dean R Campagna; Geng Tian; Yuan Shi; Verena Dederer; Mona Kawan; Nathalie Kuehnle; Joao A Paulo; Yu Yao; Mitchell J Weiss; Monica J Justice; Steven P Gygi; Mark D Fleming; Daniel Finley
Journal:  Science       Date:  2017-08-04       Impact factor: 47.728

Review 3.  Spectrin's chimeric E2/E3 enzymatic activity.

Authors:  Steven R Goodman; Rachel Petrofes Chapa; Warren E Zimmer
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

4.  A new duet in cancer biology: AMPK the typical and UBE2O the atypical.

Authors:  Isabelle K Vila; Su Jung Song; Min Sup Song
Journal:  Mol Cell Oncol       Date:  2017-03-17

Review 5.  The exportomer: the peroxisomal receptor export machinery.

Authors:  Harald W Platta; Stefanie Hagen; Ralf Erdmann
Journal:  Cell Mol Life Sci       Date:  2012-09-15       Impact factor: 9.261

6.  A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity.

Authors:  Isabelle K Vila; Mi Kyung Park; Stephanie Rebecca Setijono; Yixin Yao; Hyejin Kim; Pierre-Marie Badin; Sekyu Choi; Vihang Narkar; Sung-Woo Choi; Jongkyeong Chung; Cedric Moro; Su Jung Song; Min Sup Song
Journal:  JCI Insight       Date:  2019-07-11

7.  Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6.

Authors:  Xiaofei Zhang; Juan Zhang; Andreas Bauer; Long Zhang; Douglas W Selinger; Chris X Lu; Peter Ten Dijke
Journal:  EMBO J       Date:  2013-03-01       Impact factor: 11.598

8.  Inhibition of hepatitis C virus replication by arsenic trioxide.

Authors:  Der-Ren Hwang; Yuan-Chin Tsai; Jin-Ching Lee; Kuo-Kuei Huang; Ren-Kuo Lin; Chia-Hua Ho; Jeng-Min Chiou; Ying-Ting Lin; John T A Hsu; Chau-Ting Yeh
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

9.  Anatomy of the E2 ligase fold: implications for enzymology and evolution of ubiquitin/Ub-like protein conjugation.

Authors:  A Maxwell Burroughs; Marcie Jaffee; Lakshminarayan M Iyer; L Aravind
Journal:  J Struct Biol       Date:  2008-01-01       Impact factor: 2.867

10.  A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system.

Authors:  Sjoerd J L van Wijk; Sjoerd J de Vries; Patrick Kemmeren; Anding Huang; Rolf Boelens; Alexandre M J J Bonvin; H Th Marc Timmers
Journal:  Mol Syst Biol       Date:  2009-08-18       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.